ANPE

ANPE
Name	Alanyl aminopeptidase, membrane (CD13)
Other names	Aminopeptidase N; APN; CD13; aminopeptidase M
Ec number	3.4.11.2
Gene	ANPEP
Organism	Homo sapiens
Location	plasma membrane, endosomes, brush border

ANPE is the gene encoding alanyl aminopeptidase, membrane, commonly referred to as aminopeptidase N or CD13, a zinc-dependent metalloprotease expressed on the surface of diverse cell types. The protein is implicated in peptide metabolism, cell signaling, antigen processing, viral entry, and tumor biology. ANPE intersects multiple pathways involving immune cells, epithelial barriers, and pathogens, linking to clinical conditions ranging from inflammatory disorders to cancer and infectious disease.

Etymology and Nomenclature

The name derives from enzymology and immunology traditions: the systematic enzyme name alanyl aminopeptidase denotes specificity for N-terminal alanine residues and catalytic activity, while the cluster of differentiation designation CD13 originates from hematology and monoclonal antibody mapping. Historical studies that characterized membrane peptidases referenced proteolytic classifications such as the MEROPS database and seminal biochemical work by Schechter and Berger. Alternate synonyms have appeared in literature alongside gene nomenclature committees that standardized the symbol ANPEP for human genetic and genomic databases.

Structure and Biochemistry

The encoded protein is a type II transmembrane glycoprotein of the M1 family of zinc metallopeptidases, containing a short N-terminal cytoplasmic tail, a single transmembrane helix, and a large extracellular C-terminal catalytic domain. Structural studies, including X-ray crystallography of homologs and cryo-EM of related M1 enzymes, reveal the conserved HEXXH zinc-binding motif and the GAMEN substrate-binding region characteristic of aminopeptidases. Post-translational modifications include N-linked glycosylation sites essential for trafficking and stability, disulfide bonds that stabilize tertiary structure, and proteolytic processing that can generate soluble ectodomains detected in plasma. The protein forms noncovalent homodimers or higher-order oligomers on the cell surface, influencing catalytic efficiency and lateral interactions with integrins and scaffolding proteins.

Biological Function and Mechanism

ANPE functions as an ectopeptidase trimming N-terminal amino acids from oligopeptides, modulating peptide-mediated signaling cascades in leukocytes, enterocytes, and endothelial cells. It participates in the degradation of regulatory peptides such as enkephalins, angiotensins, and chemotactic peptides, thereby regulating local concentrations of bioactive ligands. Mechanistically, catalysis proceeds via zinc-coordinated activation of a water molecule that attacks the scissile peptide bond, with substrate specificity shaped by S1 pocket residues. ANPE also acts as a receptor or co-receptor for pathogens — notable examples include coronavirus and cytomegalovirus entry pathways — and mediates leukocyte adhesion and migration through interactions with extracellular matrix proteins and CD13-binding integrins. In the intestine, brush-border localization contributes to nutrient processing and peptide absorption; in the kidney and liver, expression influences local peptide milieu.

Clinical Significance and Associated Disorders

Altered expression or activity of ANPE has been linked to a spectrum of diseases. Overexpression correlates with angiogenesis and metastasis in solid tumors such as colorectal carcinoma, hepatocellular carcinoma, and non-small cell lung carcinoma, where ANPE associates with tumor vasculature and invasive phenotypes. In hematology, CD13 is a diagnostic marker expressed on myeloid lineage cells and is leveraged in immunophenotyping acute myeloid leukemia and other myeloproliferative disorders. In infectious disease, ANPE serves as an entry factor for certain coronaviruses and as a modulator of viral tropism for human intestinal epithelium, impacting pathogenesis of viral gastroenteritis and systemic infections. Dysregulation has also been implicated in inflammatory bowel disease, ischemia–reperfusion injury, and diabetic nephropathy through effects on peptide mediators of inflammation and vascular tone.

Diagnostic and Research Methods

Detection and quantification of ANPE employ immunohistochemistry and flow cytometry using monoclonal antibodies against CD13 for cell-surface phenotyping in hematopathology and tumor biopsies. Enzymatic assays measure aminopeptidase activity using chromogenic or fluorogenic substrates in tissue homogenates, serum, or conditioned media. Molecular approaches include RT-PCR and RNA sequencing for ANPEP transcript levels, western blotting for isoforms, and mass spectrometry for glycosylation profiling. Structural and mechanistic research utilizes X-ray crystallography of catalytic domains, site-directed mutagenesis, molecular dynamics simulations, and cryo-EM to resolve oligomeric states. In vivo models employ transgenic and knockout mice to study roles in angiogenesis, leukocyte trafficking, and infection models with pathogens that exploit ANPE as a receptor.

Therapeutic Targets and Inhibitors

ANPE is a therapeutic target in oncology, inflammatory diseases, and antiviral strategies. Small-molecule zinc-chelating inhibitors such as bestatin and more selective hydroxamate-based compounds inhibit catalytic activity and have been evaluated in preclinical cancer models and clinical trials. Monoclonal antibodies and antibody–drug conjugates targeting the extracellular domain have been developed to exploit CD13 surface expression for targeted cytotoxicity. Peptide inhibitors, green tea polyphenols, and repurposed drugs have demonstrated modulation of ANPE function in vitro. Strategies include blockade of receptor-mediated viral entry, inhibition of tumor angiogenesis, and modulation of peptide-mediated inflammatory signaling. Ongoing drug discovery integrates structure-guided design, high-throughput screening, and antibody engineering to improve specificity and pharmacokinetics while minimizing off-target metalloprotease inhibition.

Category:Proteins Category:Metalloproteases Category:Cell surface receptors